How we work
The Department of Health set up Genomics England in 2013. Our aim is to deliver the 100,000 Genomes Project. Genomics England is a company owned by the Department of Health. The Secretary of State is the only shareholder.
We are governed by a Board, led by an Executive Chairman.
We work with a range of partners to deliver the 100,000 Genomes Project:
- NHS England
- Health Education England
- Public Health England
- 85 NHS Trusts and hospitals across England
100,000 Genomes Project
To identify and enrol participants for the 100,000 Genomes Project we have created NHS Genomic Medicine Centres (GMCs). Each centre includes several NHS Trusts and hospitals. GMCs recruit and consent patients. They then provide DNA samples and clinical information for analysis.
Illumina, a biotechnology company, have been commissioned to sequence the DNA of participants. They return the whole genome sequences to Genomics England. We have created a secure, monitored, infrastructure to store the genome sequences and clinical data. The data is analysed within this infrastructure and any important findings, like a diagnosis, are passed back to the patient’s doctor.
To help make sure that the project brings benefits for people who take part, we have created the Genomics England Clinical Interpretation Partnership (GeCIP). GeCIP brings together funders, researchers, NHS teams and trainees. They will analyse the data – to help ensure benefits for patients and an increased understanding of genomics. The data will also be used for medical and scientific research. This could be research into diagnosing, understanding or treating disease.
Find out more
To learn more about how we work you can read the 100,000 Genomes Project protocol (opens as PDF). It has details of the development, delivery and operation of the project. It also sets out the patient and clinical benefit, scientific and transformational objectives, the implementation strategy and the ethical and governance frameworks.